A detailed history of Godsey & Gibb Associates transactions in Embecta Corp. stock. As of the latest transaction made, Godsey & Gibb Associates holds 158 shares of EMBC stock, worth $2,237. This represents 0.0% of its overall portfolio holdings.

Number of Shares
158
Previous 178 11.24%
Holding current value
$2,237
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

SELL
$10.13 - $14.6 $202 - $292
-20 Reduced 11.24%
158 $1,000
Q3 2023

Oct 25, 2023

SELL
$15.0 - $22.17 $120 - $177
-8 Reduced 4.3%
178 $2,000
Q2 2023

Jul 25, 2023

BUY
$21.6 - $30.69 $367 - $521
17 Added 10.06%
186 $4,000
Q1 2023

Apr 18, 2023

BUY
$23.07 - $32.77 $3,898 - $5,538
169 New
169 $4,000
Q3 2022

Oct 24, 2022

BUY
$24.0 - $33.42 $4,224 - $5,881
176 New
176 $5,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $819M
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Godsey & Gibb Associates Portfolio

Follow Godsey & Gibb Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Godsey & Gibb Associates, based on Form 13F filings with the SEC.

News

Stay updated on Godsey & Gibb Associates with notifications on news.